Aravindan Narayanan
aravindannarayanan.bsky.social
Aravindan Narayanan
@aravindannarayanan.bsky.social
PhD-Senior Research Fellow at BRIC- National Centre for Cells Science (NCCS), Pune, India. My research focus on identifying cancer stem cells (CSCs)- specific druggable pathways in High-Grade Serous Ovarian Carcinoma.
Pinned
I am excited to share that part of my Ph.D. thesis, “Targeting mitochondrial translation and OXPHOS in high-grade serous ovarian carcinoma eliminates stem-like cells”, has been published in Cell Death & Disease (CDD press)!

Looking forward to your thoughts....

rdcu.be/eJSjX

lnkd.in/gski3RaX
Targeting mitochondrial translation and OXPHOS in high-grade serous ovarian carcinoma eliminates stem-like cells
Cell Death & Disease - Targeting mitochondrial translation and OXPHOS in high-grade serous ovarian carcinoma eliminates stem-like cells
rdcu.be
Reposted by Aravindan Narayanan
New podcast episode 🚨 we hear from Andreas Trumpp & Vera Thiel about trace-n-Seq, a new technology that enables the molecular characterisation at single cell resolution of neurons, innervating any organ or tumour in preclinical models.

Listen or read: magazine.eacr.org/unlocking-ca...
October 15, 2025 at 8:01 AM
I am excited to share that part of my Ph.D. thesis, “Targeting mitochondrial translation and OXPHOS in high-grade serous ovarian carcinoma eliminates stem-like cells”, has been published in Cell Death & Disease (CDD press)!

Looking forward to your thoughts....

rdcu.be/eJSjX

lnkd.in/gski3RaX
Targeting mitochondrial translation and OXPHOS in high-grade serous ovarian carcinoma eliminates stem-like cells
Cell Death & Disease - Targeting mitochondrial translation and OXPHOS in high-grade serous ovarian carcinoma eliminates stem-like cells
rdcu.be
October 9, 2025 at 10:49 AM